Guggenheim started coverage on shares of Nanobiotix (NASDAQ:NBTX – Get Free Report) in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm set a “buy” rating and a $12.00 price target on the stock. Guggenheim’s price objective would indicate a potential upside of 133.92% from the company’s current price.
Nanobiotix Stock Performance
Nanobiotix stock opened at $5.13 on Wednesday. The business has a 50-day moving average of $5.13 and a 200-day moving average of $5.93. Nanobiotix has a 1 year low of $4.14 and a 1 year high of $10.70.
Nanobiotix Company Profile
Featured Articles
- Five stocks we like better than Nanobiotix
- Conference Calls and Individual Investors
- Are Utility Stocks Running Out of Steam? What You Need to Know
- What is Put Option Volume?
- Snowflake’s Risk/Reward Profile Is Too Good To Miss
- Most Volatile Stocks, What Investors Need to Know
- Akamai: AI Tailwinds Drive Edge Computing and Security Growth
Receive News & Ratings for Nanobiotix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanobiotix and related companies with MarketBeat.com's FREE daily email newsletter.